Cat. No.
MABL-3658
Application
ELISA, FC
Isotype
Engineer antibody
Species Reactivity
Human
Clone No.
15E8
From
Recombinant Antibody
Specificity
This antibody binds human CD28, which is found on a sub‑population of T cells and activated B cells. The antibody does not react with B cells, granulocytes or monocytes. CD28 is involved in T‑cell activation, the induction of cell proliferation and cytokine production and promotion of T‑cell survival.
Alternative Names
T‑cell‑specific surface glycoprotein CD28; TP44
UniProt
P10747
Immunogen
The original mouse antibody was generated by immunizing mice with human T lymphocytes.
Application Notes
This antibody works independently of TcR/CD3 and activation of protein kinase C (PKC) for activation of T cells and enhances cytokine secretion (PMID: 1647959). This antibody is capable of stimulating T cells in combination with either murine OKT3 antibody or CDR‑mutated OKT3 Fab variants. It was found that cross‑linking of specific tumor antigens with the T‑cell‑associated CD3 and CD28 antigens can increase IL‑2 secretion, proliferation and antigen‑specific cytotoxicity in resting T cells. This cross‑linking can be achieved effectively by bispecific monoclonal antibodies (BiMAb) with specificity for both the tumor antigen and CD3 or CD28 antigen. A combination of bispecific antibodies BiMAb OKT3/HRS‑3 with reactivity against both CD3 and Hodgkin's‑lymphoma‑associated CD30 antigen and BiMAb 15E8/HRS‑3 with reactivity to both CD28 and CD30 antigen was able to activate resting T cells, represented by Jurkat cells (CD3+/CD28+) to produce IL‑2 (PMID: 7686889). This antibody was also used in another study wherein the combined use of two CD3 x CD19 plus CD28 x CD22 bispecific antibodies induced optimal interleukin 2 secretion by Jurkat T‑cell acute lymphocytic leukemia cells in the presence of target B‑cells (PMID: 7689932). This antibody also provides a co‑stimulatory signal to T cells. The scFv fragment of this antibody induced proliferation of peripheral blood mononuclear cells in the presence of anti‑CD3 or anti‑CD2 mAb and enhanced anti‑tumor activity of anti‑MUC1×anti‑CD3 bispecific antibody when tested with lymphokine‑activated killer cells with T cell phenotype (PMID: 10913626). The humanized version of this antibody is available on request.
Antibody First Published
Van Lier et al. T cell receptor/CD3 and CD28 use distinct intracellular signaling pathways/ Eur J Immunol. 1991 Jul;21(7):1775-8. PMID:1647959
Note on publication
This paper investigates whether stimulation of T cells by CD28 is dependent on the activation of protein kinase C (PKC).
Size
100 μg Purified antibody.
Concentration
1 mg/ml.
Purification
Protein A affinity purified
Buffer
PBS with 0.02% Proclin 300.
Storage Recommendation
Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C.


